Last reviewed · How we verify
NCT06046235: VESPA
Virtual Evaluations of Joint Health Using Wearable Sensors in Persons With Haemophilia (VESPA)
trial in Haemophilia in 20 participants. Status unknown.
12 December 2024
Quick facts
| Lead sponsor | East Kent Hospitals University NHS Foundation Trust |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 1 December 2024 |
| Primary completion | 12 December 2024 |
| Estimated completion | 12 December 2024 |
| Sites | 1 location across United Kingdom |
Conditions studied
- Haemophilia — all drugs for Haemophilia →
Sponsor
East Kent Hospitals University NHS Foundation Trust
Who can join
13 and older, any sex, with Haemophilia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Recent technological innovations have enabled the creation of portable and easy-to-wear sensors with incredible potential to alter the clinical practice of rehabilitation. Using wearable sensors we have gathered preliminary data in the clinical setting measuring walking ability and function. Preliminary data shows that these wearable sensors can detect improvements in walking ability and function after a 12-week physiotherapy exercise programme in boys with haemophilia. In this proposal, we want to test the use of these wearable sensors in the patient's home to remotely monitor joint health and the effects of rehabilitation for people with haemophilia. We expect that wearable sensor technology is an efficient and promising tool to evaluate and monitor joint health and pain in persons with haemophilia. If usable in the home setting, the wearable sensors have the potential to provide immediate real-time feedback on joint health and rehabilitation goals to the patient and their haemophilia care team without the patient having to leave their home. The project will also support educational activities with researchers and patients to ensure that the use of this new type of rehabilitation will be fully integrated with their future treatment and management.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06046235
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other East Kent Hospitals University NHS Foundation Trust trials
Trials by the same sponsor.
- NCT07198737 — Effect of Virtual Reality and Trans Auricular X-Vagus Nerve Stimulation for Anxiety and Depression in Chronic Shoulder P · NA · not yet recruiting
- NCT07274098 — To Test Effectiveness of Virtual Reality on Post Operative Patients 'VR-RAP@ · NA · completed
- NCT05732480 — Influence of Gut Microbiome in Gallstone Disease · recruiting
- NCT05464199 — Home-based EEG Neurofeedback for Chronic Neuropathic Pain · Phase 1 · completed
- NCT05435404 — Qualitative Study Patient & Physician Experiences Botox COVID-19 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06046235 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by East Kent Hospitals University NHS Foundation Trust
- Last refreshed: 30 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06046235.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing